The Valley Desk

ArticleTargeted oncologyPublished

Revised Recommendations for Restarting Teclistamab Following Dose Delays: Insights from the MajesTEC-1 Study on Clinical Safety, and from Simulated Pharmacokinetics and Cytokine Dynamics

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Targeted oncology
Published
Subject terms
Humans; Multiple Myeloma; Antibodies, Bispecific; Cytokines; Retrospective Studies; Female; Male; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic
PubMed ID
41886220
PubMed Central ID
PMC13222323
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal